Skip to main content

Samsung Bioepis — Deal History & Benchmarks

Total Deals
2
Across 2 therapeutic areas
Total Deal Value
$1.0B
Cumulative transaction value
Most Active Year
2024
1 deal closed
Primary TA
Women's Health
50% of deal activity

Market Analysis

Samsung Bioepis has been involved in 2 transactions totaling $1.0B across Women's Health, Ophthalmology. As a licensee (in-licensor/acquirer), they have demonstrated a preference for licensing partnerships.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Samsung Bioepis done?
Samsung Bioepis has completed 2 verified transactions tracked in our database, spanning from 2022 to 2024. These deals have a combined value of $1.0B.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating